Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
In rodent models, BPC-157 demonstrated a wide therapeutic index with no observed hepatotoxicity, nephrotoxicity, or neurotoxicity across multiple dosing regimens. Sikiric et al., Regenerative Pharmacology Reported Side Effects (Rare) While side effects are rare, some users report: Peptides like BPC-157 generally exhibit low immunogenicity and low systemic toxicity, though user-specific variables such as injection technique or gut sensitivity may influence short-term side effects. [Clinical Peptide Society Review, 2021] Is BPC-157 Safe for Long-Term Use
In the phase II trial, CagriSema has similar efficacy to tirzepatide.
(2022) in Cell Metabolism provides the foundational discovery data
These latter health benefits, as well as associated improvements in cardiovascular and cognitive function , should continue with longer-term use
:
US$ 20.24
US$ 23.68
US$ 21.10
US$ 22.27
